What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Schizophrenia
Internal medicine, Schizophrenia, Neuroscience, Genome-wide association study and Psychosis are his primary areas of study.
His research integrates issues of Endocrinology, Psychiatry, Placebo, Antipsychotic and Positive and Negative Syndrome Scale in his study of Internal medicine.
Steven G. Potkin interconnects Psychometrics and Placebo-controlled study in the investigation of issues within Psychiatry.
His Schizophrenia study integrates concerns from other disciplines, such as Clinical psychology, Platelet monoamine oxidase and Audiology.
His research in Neuroscience intersects with topics in White matter and Voxel-based morphometry.
The concepts of his Genome-wide association study study are interwoven with issues in Alzheimer's disease, Genetic association and Bioinformatics.
His most cited work include:
- Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). (963 citations)
- Measurement of Premorbid Adjustment in Chronic Schizophrenia (953 citations)
- Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. (866 citations)
What are the main themes of his work throughout his whole career to date?
Steven G. Potkin mainly investigates Schizophrenia, Internal medicine, Psychiatry, Neuroscience and Endocrinology.
As a part of the same scientific family, Steven G. Potkin mostly works in the field of Schizophrenia, focusing on Audiology and, on occasion, Cognition.
His work deals with themes such as Placebo, Oncology, Atypical antipsychotic and Positive and Negative Syndrome Scale, which intersect with Internal medicine.
His Psychiatry research includes elements of Haloperidol and Clinical trial.
Steven G. Potkin has researched Antipsychotic in several fields, including Schizoaffective disorder, Pharmacogenetics, Tolerability and Pharmacology.
His Neuroimaging research is multidisciplinary, incorporating elements of Disease and Artificial intelligence.
He most often published in these fields:
- Schizophrenia (30.80%)
- Internal medicine (27.83%)
- Psychiatry (21.34%)
What were the highlights of his more recent work (between 2013-2021)?
- Schizophrenia (30.80%)
- Neuroscience (18.18%)
- Psychiatry (21.34%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Schizophrenia, Neuroscience, Psychiatry, Internal medicine and Neuroimaging.
The various areas that Steven G. Potkin examines in his Schizophrenia study include Pharmacogenetics and Functional magnetic resonance imaging.
His study connects Genome-wide association study and Neuroscience.
In the field of Psychiatry, his study on Positive and Negative Syndrome Scale, Psychosis and Atypical antipsychotic overlaps with subjects such as In patient.
His Internal medicine research includes themes of Aripiprazole, Endocrinology, Oncology and Paliperidone Palmitate.
His Neuroimaging research is multidisciplinary, relying on both Cognition, Alzheimer's disease, Disease, Artificial intelligence and Pattern recognition.
Between 2013 and 2021, his most popular works were:
- Common genetic variants influence human subcortical brain structures. (610 citations)
- Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium (595 citations)
- Dynamic functional connectivity analysis reveals transient states of dysconnectivity in schizophrenia (563 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Schizophrenia
His primary areas of study are Schizophrenia, Neuroscience, Psychiatry, Neuroimaging and Alzheimer's disease.
His Schizophrenia study combines topics in areas such as Audiology, Psychosis, Prefrontal cortex and Brain mapping.
His biological study spans a wide range of topics, including Genome-wide association study and Voxel-based morphometry.
His studies in Psychiatry integrate themes in fields like Internal medicine and Clinical psychology.
His work carried out in the field of Neuroimaging brings together such families of science as Alzheimer's Disease Neuroimaging Initiative, Data mining, Schizophrenia, Artificial intelligence and Neuroinformatics.
His Alzheimer's disease research incorporates elements of Nerve growth factor, Neurotrophic factors and Cholinergic neuron.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
